Publications in collaboration with researchers from KU Leuven (99)

2024

  1. Evidence-based definition of hypoprolactinemia in European men aged 40–86 years: the European male ageing study

    Reviews in Endocrine and Metabolic Disorders

  2. Hyponatremia, hypernatremia and impairment of functional, psychological and sexual domains

    Journal of Endocrinological Investigation, Vol. 47, Núm. 4, pp. 1005-1014

  3. Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold

    Aging Male, Vol. 27, Núm. 1

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  2. Does testosterone influence the association between sleep and frailty in men: results from the European Male Aging Study

    BMC Geriatrics, Vol. 23, Núm. 1

  3. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

  4. Number of CAG repeats and mortality in middle aged and older men

    Clinical Endocrinology, Vol. 99, Núm. 6, pp. 559-565

  5. Sarcopenia-defining parameters, but not sarcopenia, are associated with cognitive domains in middle-aged and older European men

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 14, Núm. 3, pp. 1520-1532

2022

  1. Aging Men With Insufficient Vitamin D Have a Higher Mortality Risk: No Added Value of its Free Fractions or Active Form

    The Journal of clinical endocrinology and metabolism, Vol. 107, Núm. 3, pp. e1212-e1220

  2. Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort

    Andrology, Vol. 10, Núm. 7, pp. 1328-1338

  3. Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status

    Age and ageing, Vol. 51, Núm. 4

  4. Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men: The European Male Ageing Study.

    Physiology and Behavior, Vol. 252

  5. The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort

    Frontiers in Endocrinology, Vol. 13

2021

  1. Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 12, Núm. 6, pp. 1818-1831

  2. Self-Reported Shorter Than Desired Ejaculation Latency and Related Distress—Prevalence and Clinical Correlates: Results From the European Male Ageing Study

    Journal of Sexual Medicine, Vol. 18, Núm. 5, pp. 908-919

2020

  1. Repositioning of the global epicentre of non-optimal cholesterol

    Nature, Vol. 582, Núm. 7810, pp. 73-77

2019

  1. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature

2018

  1. Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants

    International Journal of Epidemiology, Vol. 47, Núm. 3, pp. 872-883i

  2. Elevated luteinizing hormone despite normal testosterone levels in older men—natural history, risk factors and clinical features

    Clinical Endocrinology, Vol. 88, Núm. 3, pp. 479-490

  3. Reproductive hormone levels predict changes in frailty status in community-dwelling older men: European male ageing study prospective data

    Journal of Clinical Endocrinology and Metabolism, Vol. 103, Núm. 2, pp. 701-709